Literature DB >> 28799086

Phase I and phase II metabolite identification of rutaecarpine in freshly isolated hepatocytes from male Sprague-Dawley rats.

Dong Wook Lee1, Youra Kang1, Mi Jeong Kang1, Keumhan Noh1, Ju Hyun Kim1, Mahesh R Nepal1, Rajina Shakya1, Yu-Jeong Lee1, Yurngdong Jahng1, Sangkyu Lee2, Jung-Ae Kim1, Tae Cheon Jeong3.   

Abstract

Rutaecarpine, an alkaloid originally isolated from Evodia rutaecarpa, has been used for the treatment of gastrointestinal disorders in Asia. In the present study, the phase I and phase II metabolites of rutaecarpine were investigated in freshly isolated hepatocytes from male Sprague-Dawley rats. The individual metabolites were characterized via liquid chromatography-tandem mass spectrometry. The incubation of rutaecarpine with freshly isolated hepatocytes for 2 h yielded five major phase I metabolites. In addition, three glucuronide conjugates and four sulfate conjugates were observed. Because the majority of metabolites observed in vivo were identified, freshly isolated hepatocytes might be useful for the identification of certain metabolites formed from drug candidates from a reduced number of experimental animals.

Entities:  

Keywords:  Hepatocytes; Metabolism; Phase I; Phase II; Rutaecarpine

Mesh:

Substances:

Year:  2017        PMID: 28799086     DOI: 10.1007/s12272-017-0937-7

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  1 in total

1.  Characterization of the in Vitro Metabolic Profile of Evodiamine in Human Liver Microsomes and Hepatocytes by UHPLC-Q Exactive Mass Spectrometer.

Authors:  Zhaowei Zhang; Tianzi Fang; Hongyun Zhou; Jie Yuan; Qingwang Liu
Journal:  Front Pharmacol       Date:  2018-02-22       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.